Local delivery of CpG oligodeoxynucleotides induces rapid changes in the genital mucosa and inhibits replication, but not entry, of herpes simplex virus type 2

被引:124
作者
Ashkar, AA [1 ]
Bauer, S
Mitchell, WJ
Vieira, J
Rosenthal, KL
机构
[1] McMaster Univ, Hlth Sci Ctr, Dept Pathol & Mol Med, Ctr Gene Therapeut, Hamilton, ON L8N 3Z5, Canada
[2] Tech Univ Munich, Inst Med Microbiol Immunol & Hyg, D-8000 Munich, Germany
[3] Univ Missouri, Dept Vet Pathobiol, Columbia, MO 65211 USA
[4] Univ Washington, Dept Lab Med, Seattle, WA 98109 USA
[5] Fred Hutchinson Canc Res Ctr, Program Infect Dis, Seattle, WA 98109 USA
关键词
D O I
10.1128/JVI.77.16.8948-8956.2003
中图分类号
Q93 [微生物学];
学科分类号
071005 ; 100705 ;
摘要
Mucosal surfaces are the entry sites for the vast majority of infectious pathogens and provide the first line of defense against infection. In addition to the epithelial barrier, the innate immune system plays a key role in recognizing and rapidly responding to invading pathogens via innate receptors, such as Toll-like receptors (TLR). Bacterial CpG DNA, a potent activator of innate immunity, is recognized by TLR9. Here, we confirm that local mucosal, but not systemic, delivery of CpG oligodeoxynucleotides (ODN) to the genital tract protects mice from a subsequent lethal vaginal herpes simplex virus type 2 (HSV-2) challenge. Since these effects were so local in action, we examined the genital mucosa. Local delivery of CpG ODN induced rapid proliferation and thickening of the genital epithelium and caused significant recruitment of inflammatory cells to the submucosa. Local CpG ODN treatment also resulted in inhibition of HSV-2 replication but had no effect on HSV-2 entry into the genital mucosa. CpG ODN-induced protection against HSV-2 was not associated with early increases in gamma inierferon (IFN-gamma) secretion in the genital tract, and CpG ODN-treated IFN-gamma(-/-) mice were protected from subsequent challenge with a lethal dose of HSV-2. Treatment of human HEK-293 cells transfected with murine TLR9 showed that the antiviral activity of CpG ODN was mediated through TLR9. These studies suggest that local induction of mucosal innate immunity can provide protection against sexually transmitted infections, such as HSV-2 or possibly human immunodeficiency virus, at the mucosal surfaces.
引用
收藏
页码:8948 / 8956
页数:9
相关论文
共 37 条
[1]   In the absence of T cells, natural killer cells protect from mortality due to HSV-1 encephalitis [J].
Adler, H ;
Beland, JL ;
Del-Pan, NC ;
Kobzik, L ;
Sobel, RA ;
Rimm, IJ .
JOURNAL OF NEUROIMMUNOLOGY, 1999, 93 (1-2) :208-213
[2]  
Ashkar Ali A., 2002, Current Molecular Medicine (Hilversum), V2, P545, DOI 10.2174/1566524023362159
[3]   Human TLR9 confers responsiveness to bacterial DNA via species-specific CpG motif recognition [J].
Bauer, S ;
Kirschning, CJ ;
Häcker, H ;
Redecke, V ;
Hausmann, S ;
Akira, S ;
Wagner, H ;
Lipford, GB .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 2001, 98 (16) :9237-9242
[4]  
Benencia F, 1999, IMMUNOLOGY, V98, P363
[5]  
Chang MA, 2000, INVEST OPHTH VIS SCI, V41, P4281
[6]  
Chuang TH, 2002, J LEUKOCYTE BIOL, V71, P538
[7]   Humoral response to herpes simplex virus is complement-dependent [J].
Da Costa, XJ ;
Brockman, MA ;
Alicot, E ;
Ma, MH ;
Fischer, MB ;
Zhou, XN ;
Knipe, DM ;
Carroll, MC .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1999, 96 (22) :12708-12712
[8]  
Elkins KL, 1999, J IMMUNOL, V162, P2291
[9]   Intranasal immunization with CpG oligodeoxynucleotides as an adjuvant dramatically increases IgA and protection against herpes simplex virus-2 in the genital tract [J].
Gallichan, WS ;
Woolstencroft, RN ;
Guarasci, T ;
McCluskie, MJ ;
Davis, HL ;
Rosenthal, KL .
JOURNAL OF IMMUNOLOGY, 2001, 166 (05) :3451-3457
[10]   Interleukin-12-and gamma interferon-dependent protection against malaria conferred by CpG oligodeoxynucleotide in mice [J].
Gramzinski, RA ;
Doolan, DL ;
Sedegah, M ;
Davis, HL ;
Krieg, AM ;
Hoffman, SL .
INFECTION AND IMMUNITY, 2001, 69 (03) :1643-1649